Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 10;1(1):1000003.
doi: 10.13188/2325-4653.1000003.

Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics

Affiliations

Exploitation of the Macrophage Mannose Receptor (CD206) in Infectious Disease Diagnostics and Therapeutics

Abul K Azad et al. J Cytol Mol Biol. .

Abstract

The macrophage mannose receptor (MR, CD206) is a C-type lectin expressed predominantly by most tissue macrophages, dendritic cells and specific lymphatic or endothelial cells. It functions in endocytosis and phagocytosis, and plays an important role in immune homeostasis by scavenging unwanted mannoglycoproteins. More attention is being paid to its particularly high expression in tissue pathology sites during disease such the tumor microenvironment. The MR recognizes a variety of microorganisms by their mannan-coated cell wall, which is exploited by adapted intracellular pathogens such as Mycobacterium tuberculosis, for their own survival. Despite the continued development of drug delivery technologies, the targeting of agents to immune cells, especially macrophages, for effective diagnosis and treatment of chronic infectious diseases has not been addressed adequately. In this regard, strategies that optimize MR-mediated uptake by macrophages in target tissues during infection are becoming an attractive approach. We review important progress in this area.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic diagram for the roles of the macrophage mannose receptor (MR, CD206) in pathogen recognition [e.g., Mycobacterium tuberculosis (M.tb)]; and in specific binding of mannosylated liposomes, siRNAs, various drug molecules, and radioisotopes like 99Tc as well as MR-nanobodies.
Figure 2
Figure 2
Schematic diagram of the granuloma microenvironment to illustrate the cellular architecture of a typical tuberculosis (TB) granuloma, where M.tb is contained by various immune cells including macrophages and foamy cells, which are predicted to express abundant levels of the MR. Neutrophils may also be present when there is a large amount of necrosis and tissue destruction. Since the MR is a rapidly recycling receptor, mannosylated imaging, diagnostic and chemotherapeutic agents efficiently bound to the MR are delivered to and accumulate in receptor-containing cells of the target tissues.

References

    1. WHO. Global Tuberculosis Report 2012. 2012
    1. Fauci AS, Touchette NA, Folkers GK. Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases. Emerg Infect Dis. 2005;11:519–525. - PMC - PubMed
    1. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, et al. Macrophage receptors and immune recognition. Annu Rev Immunol. 2005;23:901–944. - PubMed
    1. Martinez-Pomares L, Linehan SA, Taylor PR, Gordon S. Binding properties of the mannose receptor. Immunobiology. 2001;204:527–535. - PubMed
    1. Allavena P, Chieppa M, Monti P, Piemonti L. From pattern recognition receptor to regulator of homeostasis: the double-faced macrophage mannose receptor. Crit Rev Immunol. 2004;24:179–192. - PubMed